Literature DB >> 2885087

Parkinson's disease and dementia.

Y Agid, M Ruberg, B Dubois, B Pillon, G Cusimano, R Raisman, R Cash, F Lhermitte, F Javoy-Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2885087

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  7 in total

1.  Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

4.  Dysphagia and dementia in subjects with Parkinson's disease.

Authors:  J E Bine; E M Frank; H L McDade
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

5.  Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.

Authors:  Paul Ardayfio; Jisook Moon; Ka Ka Amanda Leung; Dong Youn-Hwang; Kwang-Soo Kim
Journal:  Neurobiol Dis       Date:  2008-06-04       Impact factor: 5.996

6.  Allocortical neurofibrillary changes in progressive supranuclear palsy.

Authors:  H Braak; K Jellinger; E Braak; J Bohl
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Authors:  Hubert H Fernandez; Gregory P Crucian; Michael S Okun; Catherine C Price; Dawn Bowers
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.